UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cancer Therapy-Associated Thrombosis

Arteriosclerosis, thrombosis, and vascular biology, 2021-04, Vol.41 (4), p.1291-1305

2021

Volltextzugriff (PDF)

Role of Tissue Factor in Cancer

Journal of clinical oncology, 2009-10, Vol.27 (29), p.4834-4838

2009

Volltextzugriff (PDF)

An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study

Haematologica (Roma), 2021-08, Vol.106 (8), p.2161-2169

2021

Volltextzugriff (PDF)

Applicability of the Curaçao Criteria for the Diagnosis of Hereditary Hemorrhagic Telangiectasia in the Pediatric Population

The Journal of pediatrics, 2018-06, Vol.197, p.207-213

2018

Volltextzugriff (PDF)

Integration of clinical parameters, genotype and epistaxis severity score to guide treatment for hereditary hemorrhagic telangiectasia associated bleeding

Orphanet journal of rare diseases, 2020-07, Vol.15 (1), p.1-185, Article 185

2020

Volltextzugriff (PDF)

Challenges in diagnosis and management of acquired factor XIII (FXIII) inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-11, Vol.24 (6), p.e417-e420

2018

Volltextzugriff (PDF)

RBC barcoding allows for the study of erythrocyte population dynamics and P. falciparum merozoite invasion

PloS one, 2014-07, Vol.9 (7), p.e101041-e101041

2014

Volltextzugriff (PDF)

Effect of chemotherapy and longitudinal analysis of circulating extracellular vesicle tissue factor activity in patients with pancreatic and colorectal cancer

Research and practice in thrombosis and haemostasis, 2020-05, Vol.4 (4), p.636-643

2020

Volltextzugriff (PDF)

Hereditary hemorrhagic telangiectasia (HHT): a practical guide to management

Hematology, 2021-12, Vol.2021 (1), p.469-477

2021

Volltextzugriff (PDF)

Secondary Immune Thrombocytopenia in Metastatic Renal Cell Carcinoma: A Case Report and Discussion of the Literature

Case reports in oncology, 2020-11, Vol.13 (3), p.1349-1356

2020

Volltextzugriff (PDF)

Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity

Thrombosis research, 2012-02, Vol.129 (2), p.197-203

2012

Volltextzugriff (PDF)

Platelet transfusion for patients with platelet dysfunction: effectiveness, mechanisms, and unanswered questions

Current opinion in hematology, 2020-11, Vol.27 (6), p.378-385

2020

Volltextzugriff (PDF)

Plasma protein profiling: Unique and stable features of individuals

Proteomics (Weinheim), 2005-10, Vol.5 (15), p.4012-4024

2005

Volltextzugriff (PDF)

Host iron status and iron supplementation mediate susceptibility to erythrocytic stage Plasmodium falciparum

Nature communications, 2014-07, Vol.5 (1), p.4446-4446, Article 4446

2014

Volltextzugriff (PDF)

Characteristics and outcomes of venous thromboembolism in patients with hereditary hemorrhagic telangiectasia

Thrombosis research, 2018-09, Vol.169, p.41-43

2018

Volltextzugriff (PDF)

PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI

Blood, 2012-05, Vol.119 (22), p.5285-5293

2012

Volltextzugriff (PDF)

Specifications of the ACMG/AMP Variant Curation Guidelines for Hereditary Hemorrhagic Telangiectasia Genes—ENG and ACVRL1

Human mutation, 2024-05, Vol.2024, p.1-13

2024

Volltextzugriff (PDF)

Race, rituximab, and relapse in TTP

Blood, 2022-09, Vol.140 (12), p.1335-1344

2022

Volltextzugriff (PDF)

Therapeutic plasma exchange taper does not decrease exacerbations in immune thrombotic thrombocytopenic purpura patients

Transfusion (Philadelphia, Pa.), 2020-08, Vol.60 (8), p.1676-1680

2020

Volltextzugriff (PDF)

Accuracy of a modified 4Ts score in predicting heparin-induced thrombocytopenia in critically ill patients: A pilot study

Journal of critical care, 2022-02, Vol.67, p.88-94

2022

Volltextzugriff (PDF)

Biopreservation of RBCs for in vitro Plasmodium falciparum culture

British journal of haematology, 2016-11, Vol.175 (4), p.741-744

2016

Volltextzugriff (PDF)

Initiating and Managing Patients with Venous Thromboembolism on Anticoagulant Drugs: A Practical Overview

Seminars in interventional radiology, 2017-03, Vol.34 (1), p.03-10

2017

Volltextzugriff (PDF)

Evaluation of 4Ts score inter-rater agreement in patients undergoing evaluation for heparin-induced thrombocytopenia

Blood coagulation & fibrinolysis, 2021-07, Vol.32 (5), p.328-334

2021

Volltextzugriff (PDF)

Impact of a multidisciplinary workflow on safety and management of patients with heparin-induced thrombocytopenia

American journal of health-system pharmacy, 2021-01, Vol.78 (1), p.49-59

2021

Volltextzugriff (PDF)

Tissue factor and tissue factor pathway inhibitor as key regulators of global hemostasis: measurement of their levels in coagulation assays

Seminars in thrombosis and hemostasis, 2010-10, Vol.36 (7), p.764-771

2010

Volltextzugriff (PDF)

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(85)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(69)
Life Sciences & Biomedicine
(66)
Humans
(50)
Hematology
(35)
Female
(19)
Male
(19)
Adult
(17)
Cardiovascular System & Cardiology
(16)
Peripheral Vascular Disease
(16)
Animals
(13)
Hereditary Hemorrhagic Telangiectasia
(12)
Middle Aged
(12)
Hemorrhage
(9)
Anemia
(8)
Biological And Medical Sciences
(8)
Patients
(8)
Thrombosis
(8)
Bleeding
(7)
Medical Sciences
(7)
Telangiectasia, Hereditary Hemorrhagic - Complications
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Cancer Therapy-Associated Thrombosis

Role of Tissue Factor in Cancer

An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study

Applicability of the Curaçao Criteria for the Diagnosis of Hereditary Hemorrhagic Telangiectasia in the Pediatric Population

Integration of clinical parameters, genotype and epistaxis severity score to guide treatment for hereditary hemorrhagic telangiectasia associated bleeding

Challenges in diagnosis and management of acquired factor XIII (FXIII) inhibitors

RBC barcoding allows for the study of erythrocyte population dynamics and P. falciparum merozoite invasion

Effect of chemotherapy and longitudinal analysis of circulating extracellular vesicle tissue factor activity in patients with pancreatic and colorectal cancer

Hereditary hemorrhagic telangiectasia (HHT): a practical guide to management

Secondary Immune Thrombocytopenia in Metastatic Renal Cell Carcinoma: A Case Report and Discussion of the Literature

Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity

Platelet transfusion for patients with platelet dysfunction: effectiveness, mechanisms, and unanswered questions

Plasma protein profiling: Unique and stable features of individuals

Host iron status and iron supplementation mediate susceptibility to erythrocytic stage Plasmodium falciparum

Characteristics and outcomes of venous thromboembolism in patients with hereditary hemorrhagic telangiectasia

PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI

Specifications of the ACMG/AMP Variant Curation Guidelines for Hereditary Hemorrhagic Telangiectasia Genes—ENG and ACVRL1

Race, rituximab, and relapse in TTP

Therapeutic plasma exchange taper does not decrease exacerbations in immune thrombotic thrombocytopenic purpura patients

Accuracy of a modified 4Ts score in predicting heparin-induced thrombocytopenia in critically ill patients: A pilot study

Biopreservation of RBCs for in vitro Plasmodium falciparum culture

Initiating and Managing Patients with Venous Thromboembolism on Anticoagulant Drugs: A Practical Overview

Evaluation of 4Ts score inter-rater agreement in patients undergoing evaluation for heparin-induced thrombocytopenia

Impact of a multidisciplinary workflow on safety and management of patients with heparin-induced thrombocytopenia

Tissue factor and tissue factor pathway inhibitor as key regulators of global hemostasis: measurement of their levels in coagulation assays

Suchergebnisse filtern